Significance of elevated levels of collagen type IV and hyaluronic acid in gastric juice and serum in gastric cancer and precancerous lesion

Digestive Diseases and Sciences

Volumn 56, Issue 7, 2011, Pages 2001-2008

  Ruan, Hai Ling ^a   Hong, Ru Tao ^a   Xie, Hui Jun ^a   Hu, Nai Zhong ^a   Xu, Jian Ming ^a   Zhang, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cathepsin D; Collagen type IV; Hyaluronic acid; Immunohistochemistry; Radioimmunoassay; Stomach neoplasms

Indexed keywords

CATHEPSIN D; COLLAGEN TYPE 4; HYALURONIC ACID; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BLOOD SAMPLING; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GASTROINTESTINAL DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; STAINING; STOMACH; STOMACH BIOPSY; STOMACH CANCER; STOMACH JUICE; STOMACH LESION; TOTAL STOMACH RESECTION;

ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; CARCINOMA; CATHEPSIN D; COLLAGEN TYPE IV; FEMALE; GASTRIC JUICE; HUMANS; HYALURONIC ACID; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959713959     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1571-8     Document Type: Article

References (34)

1. Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125:666-673.
2. Charalabopoulos K, Mittari E, Karakosta A, Golias C, Batistatou A. Integrins adhesion molecules and some of their ligands in laryngeal cancer. Exp Oncol. 2005;27:86-90. (Pubitemid 41025726)
3. Dragutinović V, Izrael-Zivković L, Radovanović N. Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer. Dig Dis Sci. 2009;54:1203-1207.
4. Mazouni C, Arun B, André F, et al. Collagen IV levels are elevated in the serum of patients with primary breast cancer compared with healthy volunteers. Br J Cancer. 2008;99:68-71.
5. Setälä LP, Tammi MI, Tammi RH, et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer. 1999;79:1133-1138. (Pubitemid 29087886)
6. Abbott DE, Margaryan NV, Jeruss JS, et al. Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther. 2010;9:23-30.
7. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer. 2010;116: 2941-2953.
8. Baba Y, Iyama K, Ikeda K, et al. Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions. J Gastroenterol. 2007;42:874-880. (Pubitemid 350142767)
9. Allgayer H, Babic R, Grützner KU, et al. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis. Cancer. 1997;80:179-187. (Pubitemid 27282308)
10. Szumilo J, Burdan F, Zinkiewicz K, et al. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma. Folia Histochem Cytobiol. 2009;47:571-578.
11. Hewitt RE, Powe DG, Carter GI, Turner DR, Price JE. Basement membrane collagen-IV synthesis in colorectal tumors. Int J Cancer. 1992;51:530-536.
12. Tanjore H, Kalluri R. The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol. 2006;168:715-717. (Pubitemid 43327723)
13. ACh Lazaris, Tzoumani AN, Thimara I, et al. Immunohistochemical assessment of basement membrane components in colorectal cancer: prognostic implications. J Exp Clin Cancer Res. 2003;22:599-606. (Pubitemid 38222046)
14. Marasà L, Marasà S, Sciancalepore G, Collagen IV. laminin, fibronectin, vitronectin. Comparative study in basal cell carcinoma. Correlation between basement membrane molecules expression and invasive potential. G Ital Dermatol Venereol. 2008;143:169-173.
15. Ohlund D, Lundin C, Ardnor B, Oman M, Naredi P, Sund M. Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer. 2009;101:91-97.
16. Mazouni C, Arun B, André F, Collagen IV, et al. Levels are elevated in the serum of patients with primary breast cancer compared with healthy volunteers. Br J Cancer. 2008;99:68-71.
17. Korenaga D, Orita H, Maekawa S, Itasaka H, Ikeda T, Sugimachi K. Peritoneal collagen type IV concentration in adenocarcinoma of the gastrointestinal tract and its relationship to histological differentiation, metastasis, and survival. Surg Today. 1998;28: 780-786. (Pubitemid 28374391)
18. McDonald JA, Camenisch TD. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J. 2002;19:331-339. (Pubitemid 37174563)
19. Auvinen P, Tammi R, Parkkinen J, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol. 2000;156: 529-536. (Pubitemid 30643808)
20. Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, Simpson MA. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol. 2009;174:1027-1036.
21. Gomez CS, Gomez P, Knapp J, Jorda M, Soloway MS, Lokeshwar VB. Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. J Urol. 2009; 182:1350-1356.
22. Vizoso FJ, del Casar JM, Corte MD, et al. Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol. 2004;30:318-324. (Pubitemid 38425652)
23. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol. 2005;98: 193-202. (Pubitemid 41019105)
24. Gao ZL, Zhang C, Du GY, Lu ZJ. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology. 2007;54:1591-1595. (Pubitemid 47203480)
25. Yabushita H, Kishida T, Fusano K, et al. Role of hyaluronan and hyaluronan synthase in endometrial cancer. Oncol Rep. 2005;13: 1101-1105.
26. Zaidi N, Maurer A, Nieke S, Kalbacher H. Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun. 2008;376:5-9.
27. Hu L, Roth JM, Brooks P, Luty J, Karpatkin S. Thrombin upregulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res. 2008;68:4666-4673.
28. Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology. 2008;55:388-393. (Pubitemid 351741467)
29. Szajda SD, Snarska J, Roszkowska-Jakimiec W, et al. Activity of cathepsin D in the blood serum and urine of patients with cancer of the stomach, pancreas and liver. Pol Arch Med Wewn. 2006; 116:1150-1154.
30. Ikeguchi M, Fukuda K, Oka S, et al. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma. Oncology. 2001;61:71-78. (Pubitemid 32727591)
31. García I, Vizoso F, Suárez C, et al. Relationship of tumoral hyaluronic acid and cathepsin D contents with histological type of gastric carcinoma. Int J Biol Markers. 2000;15:215-218.
32. Goishi H, Tanaka S, Haruma K, et al. Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep. 2000; 7:713-718.
33. Ikeguchi M, Fukuda K, Oka S, et al. Micro-lymph node metastasis and its correlation with cathepsin D expression in early gastric cancer. J Surg Oncol. 2001;77:188-194. (Pubitemid 32645774)
34. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis. 2004; 21:91-106. (Pubitemid 38988083)